# Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

> **NCT07698288** · NA · COMPLETED · sponsor: **ADIUM** · enrollment: 66 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Tamsulosin 0.4 mg ER tablet
- **DRUG:** Tamsulosin 0.4 mg ER tablet

## Key facts

- **NCT ID:** NCT07698288
- **Lead sponsor:** ADIUM
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-12
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-04-16
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698288, "Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*